Jun. 07, 2017
By Garrett Thompson, AuD Recall in Part 1 of this series that two underlying fears of many audiologists regarding the creation of a new category of products called OTCs were brought to the surface. Part 2 continues to poke around at the data as it relates to OTC hearing devices. Study #1 In a placebo-controlled double-blind randomized clinical